ADMA Biologics

ADMA NASDAQ
3.890
0.000
0.00%
After Hours: 3.880 -0.01 -0.26% 18:32 07/19 EDT
Open
3.890
Prev Close
3.890
High
3.950
Low
3.870
Volume
555.80K
Avg Vol (3M)
945.79K
52 Week High
6.96
52 Week Low
2.080
% Turnover
1.23%
Market Cap
176.28M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers ADMA Biologics ADMA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease.
MORE >

Recently

Name
Price
%Change